Professor in Urology, Northwestern University Medical School
Urology
Dr. William J. Catalona, MD
|
|
Give Review
Doctor William J. Catalona, MD is an expert in the field of Urology. He graduated from Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He received 6 awards: "America's Top Doctors", "Chicago Magazine: Top Doctors", "America's Top Doctors for Cancer", "St. Louis Magazine: Top Doctors", "Fellow (FACS)" and "Top MD". William J. Catalona, MD has written publications. He has 30 publications published with PubMed. The lastest publication is: 'Mutational landscape of aggressive prostate tumors in African American men.' He accepts all Medicare patients.
Publications
- Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer.
- The Prostate Health Index: Its Utility in Prostate Cancer Detection.
- Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.
- Mutational landscape of aggressive Prostate tumors in African American men.
- Associations of prostate Cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
- A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate Cancer and possibly more aggressive disease.
- A genetic-based approach to personalized prostate Cancer screening and treatment.
- The Prostate Health Index (phi) Selectively Identifies Clinically-Significant Prostate Cancer.
- Prostate Cancer early detection, version 1.2014.
- Vitamin d deficiency predicts Prostate biopsy outcomes.
- The Epidemiology and Clinical Implications of Genetic Variation in Prostate Cancer.
- The Prostate Health Index: a new test for the detection of prostate Cancer.
- Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.
- PSA screening in men newly diagnosed with colorectal Cancer: each according to his group's means?
- Association analysis of 9,560 prostate Cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate Cancer associa...
- Bacteriuria and antibiotic resistance in catheter Urine specimens following radical prostatectomy.
- Re: Early Detection of Prostate Cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, ...
- Prostate Cancer: The growing evidence supporting mid-life PSA testing.
- PSA enzymatic activity: A new biomarker for assessing prostate Cancer aggressiveness.
- Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration.
- Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate Cancer susceptibility.
- Personalized Prostate Specific Antigen Testing Using Genetic Variants May Reduce Unnecessary Prostate Biopsies.
- Words of wisdom. Re: Quality-of-life effects of Prostate-specific antigen screening.
- Words of wisdom. Re: Prostate-specific antigen screening for prostate Cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.
- Prostate Cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy.
- Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate Cancer : implications for management.
- Prostate specific antigen assay standardization bias could affect clinical decision making.
- PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate Cancer aggressiveness.
- Complications of open radical retropubic Prostatectomy in potential candidates for active monitoring.
Schools
Yale University School Of Medicine
Yale New Haven Hospital
Johns Hopkins Hospital
National Cancer Institute
Procedures Preformed
- Cystotomy
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- Prostate Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Stones
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
- America's Top Doctors for Cancer
- St. Louis Magazine: Top Doctors
- Fellow (FACS)
- Top MD
Education
-
Johns Hopkins University -
UCSF -
Yale-New Haven Hospital -
Yale University School of Medicine
Hospital
-
Northwestern Memorial Hospital
Drug Facts
| NPI NUMBER | 1497716724 | |
| NPPES Provider LastName | CATALONA | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Urology | |
| Total Claim Count | 171.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497716724 |
| Last Name Of The Provider | CATALONA |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Camilo J. Barros, MD |
|
Dr. Nelcar Gadrinab, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nasrullah M. Basha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Mutchnik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joceline S. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hannah J. Alphs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcelo A. Orvieto, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|